Literature DB >> 35873124

An Effective Strategy to Activate Physicians to Promote High Cardiovascular Risk Patients to Quit Smoking.

Cheng-Huang Su1, Jiann-Shing Jeng2, Shih-Te Tu3, Chien-Ning Huang4, Hung-I Yeh1.   

Abstract

Background: Adult patients cared for by cardiologists, neurologists, and diabetologists are highly vulnerable to cardiovascular diseases (CVDs), which are worsened by smoking. In the past, physicians of these three specialties at major hospitals in Taiwan always referred patients to family medicine and chest medicine departments for smoking cessation programs. However, the participation rate in these programs was unsatisfactory.
Objectives: To encourage cardiologists, neurologists, and diabetologists to provide smoking cessation treatment services (SCTSs) to their patients through an annual contest.
Methods: Sequential expert meetings, group training, a contest to reward service quantity and abstinence rate, and an annual awards ceremony were held over the past 3 years.
Results: More than 350 cardiologists, neurologists, and diabetologists were certified to provide SCTSs, and in the second half of 2020, 3716 high CVD risk patients entered smoking cessation treatment programs, with an abstinence rate exceeding 30% at 3 months. Conclusions: The strategy used in this study was effective in overcoming physician inertia to provide SCTSs and encourage high CVD risk smokers to quit smoking.

Entities:  

Keywords:  Contest; Group training; Physician inertia; Quit smoking

Year:  2022        PMID: 35873124      PMCID: PMC9295038          DOI: 10.6515/ACS.202207_38(4).20220224A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   1.800


  8 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

2.  Smoking, Smoking Cessation, and Risk of Mortality in a Japanese Working Population - Japan Epidemiology Collaboration on Occupational Health Study.

Authors:  Shamima Akter; Tohru Nakagawa; Toru Honda; Shuichiro Yamamoto; Keisuke Kuwahara; Hiroko Okazaki; Huanhuan Hu; Teppei Imai; Akiko Nishihara; Toshiaki Miyamoto; Naoko Sasaki; Takayuki Ogasawara; Akihiko Uehara; Makoto Yamamoto; Taizo Murakami; Makiko Shimizu; Masafumi Eguchi; Takeshi Kochi; Ai Hori; Satsue Nagahama; Kentaro Tomita; Maki Konishi; Ikuko Kashino; Akiko Nanri; Isamu Kabe; Tetsuya Mizoue; Naoki Kunugita; Seitaro Dohi
Journal:  Circ J       Date:  2018-09-12       Impact factor: 2.993

3.  Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.

Authors:  Meredith S Duncan; Matthew S Freiberg; Robert A Greevy; Suman Kundu; Ramachandran S Vasan; Hilary A Tindle
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

4.  A smoking cessation intervention program for family physicians.

Authors:  D M Wilson; E A Lindsay; J A Best; J R Gilbert; D G Willms; J Singer
Journal:  CMAJ       Date:  1987-10-01       Impact factor: 8.262

Review 5.  Faculty development in tobacco cessation: training health professionals and promoting tobacco control in developing countries.

Authors:  Myra L Muramoto; Harry Lando
Journal:  Drug Alcohol Rev       Date:  2009-09

6.  African-American physicians and smoking cessation counseling.

Authors:  B A Berman; A K Yancey; R Bastani; S C Grosser; A Staveren; R A Williams; D Lee
Journal:  J Natl Med Assoc       Date:  1997-08       Impact factor: 1.798

7.  Smoking cessation program in outpatient clinics of Family Medicine Department in Taiwan: a longitudinal evaluation.

Authors:  Kuang-Chieh Hsueh; Chih-Yin Chen; Yi-Hsin Yang; Chih-Ling Huang
Journal:  Eval Health Prof       Date:  2010-03       Impact factor: 2.651

8.  Internists' attitudes about clinical practice guidelines.

Authors:  S R Tunis; R S Hayward; M C Wilson; H R Rubin; E B Bass; M Johnston; E P Steinberg
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.